VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
DRTSAlpha Tau Medical Ltd.
$9.78$861M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksDRTSEarnings History

DRTS logoAlpha Tau Medical Ltd. (DRTS) Earnings History

Net Loss

7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$43M
● Net Loss
TTM EPS (Diluted)
$-0.50
Per share, diluted
YoY EPS Growth
-17.8%
Declining
Net Margin
N/A
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating MarginN/A
Gross MarginN/A
Return on Equity-61.0%
Return on Assets-44.2%
Record Annual Net Income-$8MFY2019
Record Quarterly EPS$-0.03Q2 2022
Consecutive Profitable Years0years
Q4 2025
Net Income-$12M
EPS (Diluted)$-0.14
YoY Growth-17.8%Declining
QoQ Growth-3.9%Slow

Loading earnings history...

Alpha Tau Medical Ltd. (DRTS) Earnings Overview

As of June 22, 2026, Alpha Tau Medical Ltd. (DRTS) reported trailing twelve-month net income of -$43M, reflecting -17.8% year-over-year growth. The company earned $-0.50 per diluted share over the past four quarters.

Looking at the long-term picture, DRTS's historical earnings data spans multiple years. The company achieved its highest annual net income of -$8M in fiscal 2019.

Alpha Tau Medical Ltd. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including NVCR (-$173M net income, -20.8% margin), IART (-$496M net income, -31.6% margin), ARAY (-$46M net income, -0.3% margin), DRTS has comparable earnings metrics. Compare DRTS vs NVCR →

DRTS Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
DRTS logoDRTSCurrent
-$43M$-0.50--61.0%-17.8%—
NVCR logoNVCR
-$173M$-1.52-20.8%-38.9%+21.8%
IART logoIART
-$496M$-6.44-31.6%-39.9%-7361.2%
ARAY logoARAY
-$46M$-0.37-0.3%-2.5%+90.3%
MRKR logoMRKR
-$11M$-0.56--0.0%+33.6%
RLAY logoRLAY
-$273M$-1.52-1800.6%-41.1%+31.8%
Best in group
Lowest in group

DRTS Historical Earnings Data (2019–2025)

7 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$43M-34.3%-$42M$-0.53--
2024-$32M-8.9%-$36M$-0.45--
2023-$29M+13.6%$36M$-0.42--
2022-$34M-23.8%-$32M$-0.53--
2021-$27M-207.0%-$14M$-0.67--
2020-$9M-4.9%-$9M$-0.22--
2019-$8M--$8M$-0.13--

Download Data

Export DRTS earnings history in CSV or JSON format

Free sign-in required to download data

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

7+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

DRTS — Frequently Asked Questions

Quick answers to the most common questions about buying DRTS stock.

What is DRTS earnings per share (EPS)?

DRTS trailing twelve-month (TTM) diluted EPS is $-0.50, reflecting -17.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.

What is Alpha Tau Medical Ltd.'s net income?

Alpha Tau Medical Ltd. (DRTS) trailing twelve-month net income is $-43M as of 2025. Earnings declined -17.8% year-over-year.

Is DRTS profitable?

DRTS is not currently profitable on a TTM basis, reporting a net loss of $-43M. Net margin is N/A. Investors should monitor for a return to profitability.

What is DRTS's earnings growth rate?

DRTS compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.

What are DRTS's profit margins?

Alpha Tau Medical Ltd. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -61.0%.

Is DRTS growing earnings?

DRTS earnings are declining — EPS fell -17.8% year-over-year. TTM net income dropped to $-43M. This contrasts with the 5-year CAGR of N/A.

What was DRTS's best earnings year?

Alpha Tau Medical Ltd.'s highest annual net income on record is $-8M, achieved in fiscal year 2019. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.

What were DRTS's earnings last quarter?

DRTS's most recent reported quarter was Q4 2025. Net income was $-12M with diluted EPS of $-0.14. For a full breakdown of all quarters, see the quarterly earnings table on this page.

DRTS Earnings Over Time (2019–2025)

Net income & EPS — annual and quarterly view